
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.550 | 1.550 | 0.000 |
Shares | 98.450 | 98.450 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 23.514 | 18.334 |
Price to Book | 5.180 | 3.084 |
Price to Sales | 4.428 | 2.253 |
Price to Cash Flow | 19.114 | 12.439 |
Dividend Yield | 1.511 | 2.014 |
5 Years Earnings Growth | 9.596 | 10.621 |
Name | Net % | Category Average |
---|---|---|
Technology | 28.730 | 23.863 |
Financial Services | 21.100 | 16.505 |
Healthcare | 17.600 | 13.069 |
Consumer Defensive | 16.140 | 7.536 |
Industrials | 7.490 | 11.489 |
Consumer Cyclical | 5.960 | 10.748 |
Communication Services | 2.990 | 8.003 |
Number of long holdings: 43
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 7.77 | 378.80 | -3.02% | |
SAP | DE0007164600 | 7.19 | 246.750 | -1.00% | |
Visa A | US92826C8394 | 6.59 | 342.85 | -2.00% | |
L'Oreal | FR0000120321 | 4.16 | 345.10 | +0.91% | |
Accenture | IE00B4BNMY34 | 4.10 | 304.33 | -1.36% | |
Aon | IE00BLP1HW54 | 4.04 | 394.55 | -1.25% | |
P&G | US7427181091 | 3.33 | 168.03 | -0.40% | |
Abbott Labs | US0028241000 | 3.18 | 130.82 | -0.40% | |
Relx | GB00B2B0DG97 | 3.18 | 3,887.00 | +0.70% | |
Becton Dickinson | US0758871091 | 3.08 | 227.50 | -0.53% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech B USD | 1.53B | 7.93 | 3.25 | 9.28 | ||
Adamant Medtech I USD | 1.53B | 8.05 | 3.98 | 10.06 | ||
EDM Intl S American Growth A USD | 295.38M | 16.42 | -2.50 | 11.74 | ||
LU1811047247 | 225.26M | 4.69 | -10.13 | - | ||
LU1811047593 | 225.26M | 3.96 | -10.76 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review